Genetic Full Cancer Risk

Turn Around Time:
6 Weeks

Sample Matrix:
EDTA (4ml)

What is it?

A comprehensive genetic screening designed to identify variants across 94 genes associated with hereditary cancer patterns.

This test provides advanced insights to support proactive health planning, long-term wellness strategies, and personalised risk awareness.

When to consider this test?

Recommended for individuals seeking deeper insight into their genetic profile, especially when there is:

• A personal history related to oncology conditions
• A family pattern involving common or rare cancer types
• Previous limited genetic screening requiring broader analysis
• Known hereditary variants within the family

This assessment supports a consultant-led approach to preventive health and longevity planning.

Gene List:
AIP
ALK
APC
ATM
BAP1
BLM
BMPR1A
BRCA1
BRCA2
BRIP1
BUB1B
CDC73
CDH1
CDK4
CDKN1C
CDKN2A
CEBPA
CEP57 CHEK2
CYLD
DDB2
DICER1
DIS3L2
EGFR
EPCAM
ERCC2
ERCC3
ERCC4
ERCC5
EXT1
EXT2
EZH2
FANCA
FANCB
FANCC
FANCD2
FANCE
FANCF
FANCG
FANCL
FANCM
FH
FLCN
GATA2
GPC3
HNF1A
HRAS
KIT
MAX
MEN1
MET
MLH1
MSH2
MSH6
MUTYH
NBN
NF1
NF2
NSD1
PALB2
PHOX2B
PMS1
PMS2
PRF1
PRKAR1A
PTCH1
PTEN
RAD51C
RAD51D
RB1
RECQL4
RET
RHBDF2
RUNX1
SBDS
SDHA
SDHB
SDHC
SDHD
SLX4
SMAD4
SMARCB1
STK11
SUFU
TMEM127
TP53
TSC1
TSC2
VHL
WRN
WT1
XPA
XPC